Dupilumab (anti-IL-4Rα)
Dupilumab (anti-IL-4Rα) (A2038-GRP)
Products
Description
Dupilumab (anti-IL-4Rα) is a fully human anti–interleukin-4 receptor α monoclonal antibody that inhibits both interleukin-4 (IL-4) and interleukin-13 (IL-13) signaling through blockade of the shared IL-4α subunit.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2038 |
| Target | Interleukins |